oral sel. PDE2A phosphodiesterase inhibitor
for cognition, target engagement in brain
from HTS, SBDD, and FEP claculations
J. Med. Chem., Oct. 26, 2020
Janssen Pharmaceutica NV, Beerse, BE
“compound 46”
1 min read
“compound 46” (Janssen oral selective brain-penetrant PDE2A phosphodiesterase inhibitor)
Search By Structure
- BAY 1214784
- BAY 1217224
- CC-90011
- LEO 39652
- OATD-01
- AG-636
- “compound 46”
- “compound 25”
- “lipid 10a”
- BAY-6672
- “compound 27”
- “EST73502”
- CG428
- “compound 34”
Molecules of the Month
2023
2022
2021
2020